William Seely, MD
Interventional Pain Medicine · Jackson, TNNPI 1609163880
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.4%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 63.3% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2024 at $2,838 and has fallen 66.9% since, to $940 in 2025.
Across 171 payments — averaging $50.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Nalu Medical, Inc.$1K
- Abbott$631
- SPR Therapeutics, Inc$411
- Medtronic$155
- Vertos Medical, Inc.$126
- plus $826 from 24 others
What the payments were for
- Travel & lodging$3,72943%
- Food & beverage$4,75355%
- Entertainment$1061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 91 | $5,437 |
| Nalu Medical, Inc. | 11 | $1,001 |
| Abbott | 16 | $631 |
| SPR Therapeutics, Inc | 7 | $411 |
| Medtronic | 5 | $155 |
| Vertos Medical, Inc. | 6 | $126 |
| Flowonix Medical Incorporated | 1 | $106 |
| Foundation Fusion Solutions, LLC | 1 | $101 |
| Collegium Pharmaceutical, Inc. | 5 | $73 |
| Innovation Technologies Inc | 2 | $56 |
| Gentleman Orthopedic Solutions | 1 | $51 |
| Painteq LLC | 2 | $40 |
| Vertiflex, Inc. | 2 | $39 |
| Amgen | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Pfizer | 2 | $33 |
| Relievant Medsystems, Inc. | 1 | $28 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| Bioventus LLC | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Nevro Corp. | 1 | $20 |
| AbbVie | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $17 |
| Saluda Medical Americas, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Heraeus Medical, LLC. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUPERION$973
- Nalu Neurostimulation System$812
- VERTIFLEX SUPERION$687
- SPRINT PNS System$288
- PROCLAIM$224
- INTELLIS ADAPTIVESTIM$106
- Prometra II$106
- GENERAL PAIN MANAGEMENT$104
- ETERNA$102
How this compares
$8,588 in reported general payments places this provider in the 70th percentile of 41 interventional pain medicine providers in Tennessee.
See all interventional pain medicine providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 769 | $10,461 |
| Pregabalin | 317 | $6,487 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 244 | $2,847 |
| Buprenorphine | 18 | $2,624 |
| Tramadol Hcl | 601 | $2,482 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 60 | $1,161 |
| Diclofenac Sodium | 53 | $736 |
| Baclofen | 103 | $736 |
| Duloxetine Hcl | 47 | $576 |
| Tizanidine Hcl | 36 | $478 |
| Cyclobenzaprine Hcl | 40 | $339 |
| Methylprednisolone | 34 | $249 |
| Alprazolam | 512 | $246 |
| Methocarbamol | 15 | $200 |
| Meloxicam | 34 | $134 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Jackson
- William NewtonWinchester$225K
- Ryan BearerWinchester$35K
- Michael WilkinsonJohnson City$35K
- Jacob MillsMountain Home$24K
- Matthew KangasMemphis$22K
- Matthew RupertFranklin$17K
- Adolfo CuadraKnoxville$15K
- Cameron ShawverJohnson City$15K
- Christine LeslieMorristown$12K
- Madhu YelameliColumbia$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.